(Total Views: 79)
Posted On: 08/03/2023 8:15:55 AM
Post# of 85472

$NRBO News Article - NeuroBo Pharmaceuticals Receives First Site IRB Approval for its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASH https://marketwirenews.com/news-releases/neur...41700.html


My Twitter: WhyteStocks